Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Neoplasie
06. Oktober 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 8178
Artikel 1 - 20 / 163544
Epidemiology, exposure patterns and survival of malignant mesothelioma in Apulia, Italy (1993-2025): a population-based retrospective registry study.
BMJ Open
De Maria L, Cavone D, Delvecchio G, Serio G, Caputi A, Sole S, Aloia G, Lupariello V, Pierfelice A, Sindaco A, Schino V, Stufano A, Vimercati L.
PMID: 42833719 [PubMed - indexed for MEDLINE]
Lung Cancer Screening Beyond Smoking-Based Eligibility: Evidence, Limits, and Lessons From China.
Chest
He F, Xu Y, Tu B, Liu Y, Ye W, Zeng Y, Powell CA.
PMID: 42833546 [PubMed - as supplied by publisher]
Combined amivantamab, lazertinib, and bevacizumab in patients with EGFR-mutant advanced non-small-cell lung cancer with acquired resistance to a third-generation EGFR tyrosine-kinase inhibitor (ETOP 18-21 AMAZE-lung): a prospective, international, multicentre, single-arm, phase 2 trial.
Lancet Respir Med
Soo RA, Popat S, Dafni U, de Langen AJ, Nadal E, Iranzo P, Früh M, Pérol M, Metro G, Sala MA, Cucurull Salamero M, Cerciello F, Addeo A, Dómine M, Oulkhouir Y, Cloarec N, López Castro R, Froesch P, Roschitzki-Voser H, Ruepp B, Gasca-Ruchti A, Dellaporta T, Peters S, Stahel RA, ETOP AMAZE-lung collaborators.
PMID: 42833236 [PubMed - as supplied by publisher]
Discordance between physician dose decisions and Cancer and Aging Research Group-defined vulnerability in older adults with lung cancer: A prospective observational study.
J Geriatr Oncol
Watanabe H, Hirai K, Nakauchi K, Ishii R, Tateishi K, Sonehara K, Araki T, Naito T.
PMID: 42833070 [PubMed - as supplied by publisher]
PLAG1-rearranged pulmonary metastases from pleomorphic adenoma-spectrum salivary gland neoplasms: A clinicopathologic study of metastasizing pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Pathol Res Pract
Zhang M, Xu C, Gao X, Du Q, Zheng X, Han J, Chen K, Liu E, Li S.
PMID: 42832992 [PubMed - as supplied by publisher]
EffAtt-LungNet: An attention-guided EfficientNet framework for three-class lung histopathology classification.
PLoS One
Jamil MA, Awan MDA, Bukhari F, Missen MMS, Kajla NI.
PMID: 42832554 [PubMed - indexed for MEDLINE]
Harmonizing the National Lung Screening Trial: Kernel resolution and field of view compensation.
PLoS One
Krishnan AR, Kim ME, Gao C, Rudravaram G, Schwartz T, Hucke ATS, Remedios LW, Li TZ, Xu K, Sandler KL, Martinez YF, Antic S, Maldonado F, Zuo L, Landman BA.
PMID: 42832530 [PubMed - indexed for MEDLINE]
The Role of Cancer-Related Fatalistic Beliefs and Perceived Information Ambiguity in Lung Cancer Screening Uptake.
Clin J Oncol Nurs
Zaidi M, Sarkar S, Poghosyan H.
PMID: 42832316 [PubMed - indexed for MEDLINE]
Smoking Cessation Among Underserved Patients Referred for Lung Cancer Screening: A Randomized Clinical Trial.
JAMA
Hart JL, Vachani A, Neslund-Dudas CM, Gould MK, Facktor MA, Blady S, Bayes BA, Sheu D, Madden VL, Ferrante EB, Patel N, Tian J, Whitman C, Creekmur B, Kohn R, Simoff MJ, Volpp KG, Small D, Scott ME, Holm AL, Stephens Shields AJ, Halpern SD.
PMID: 42832220 [PubMed - as supplied by publisher]
Limited Impact of Adjuvant Chemotherapy in ALK-Positive Stage II-III Lung Adenocarcinoma: A Multicenter CReGYT-03 ALK Study.
Ann Surg Oncol
Hamada A, Takamori S, Hashinokuchi A, Shimokawa M, Suda K, Katsumata S, Haratake N, Nomura K, Shimada Y, Toyoda T, Watanabe T, Hayasaka K, Ito M, Ohara S, Fukuda S, Fukami T, Oiki H, Minegishi K, Hara K, Yoshikawa M, Suzawa K, Shien K, Fujino K, Koga T, Kosai K, Kamigaichi A, Notsuda H, Matsubara T, Tane S, Abe M, Matsuo S, Wakasu S, Muto S, Okada S, Nishimura T, Toda M, Endo M, Takada K, Sekihara K, Suzuki J, Watanabe H, Fujikawa R, Hoshino H, Kuwahara K, Ikeda N, Shiono S, Soh J, Ohde Y, Tsutani Y.
PMID: 42832145 [PubMed - as supplied by publisher]
Clinical Characteristics and Outcomes of Patients with Lymphangioleiomyomatosis.
Lung
Yoon HY, Park SW, Park JS, Kwon BS, Jo YS, Jegal Y, Oh JH, Park JH, Lee JH, Yoo H, Kim BG, Kim TH, Park JK, Woo A, Song JW.
PMID: 42832099 [PubMed - indexed for MEDLINE]
Radiomics machine learning models for lung cancer early diagnosis in heterogenous multicentre chest CT data: LIBRA study results.
Eur Radiol Exp
Hunter B, Ratnakumar P, Tong D, Senthivel N, Bhamani A, Coe A, Bloch S, Kemp SV, Doran S, Navani N, Nair A, Ratoff J, Wells CE, Garner J, Nicolson A, Bunce C, Blackledge M, Devaraj A, Aboagye EO, Lee RW.
PMID: 42831983 [PubMed - indexed for MEDLINE]
Predictive modeling of lung cancer subtype with integration of clinical and thoracic imaging features to guide early brain metastasis management.
J Neurooncol
Park J, Buclez P, Lubisich J, Hanubal K, Inda A, Hui C, Harris J, Simon A.
PMID: 42831966 [PubMed - indexed for MEDLINE]
[Therapeutic success of sacituzumab govitecan in a patient with a primary diagnosis of triple-cancer: locally advanced triple-negative breast cancer, colon cancer and lung cancer.].
Recenti Prog Med
Pernice G, Spada M.
PMID: 42831722 [PubMed - indexed for MEDLINE]
Correlation of the Diagnostic Accuracy of Dual Energy Computed Tomography and Positron Emission Tomography/Computed Tomography in Mediastinal Lymph Node Staging in Lung Cancer: A Systematic Review.
Cureus
Adebayo D, England A, McEntee M, Ryan DJ, Maher M.
PMID: 42831153 [PubMed]
Dexketoprofen Trometamol Plus Sufentanil for Analgesia After Thoracoscopic Radical Resection of Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial.
Drug Des Devel Ther
Guo A, Shen M, Wang H, Sun J, Lu X.
PMID: 42830882 [PubMed - indexed for MEDLINE]
Envonalkib Versus Crizotinib in Treatment-Naive ALK-Positive Non-Small Cell Lung Cancer: Final Efficacy and Biomarker Analyses of the Randomized Phase III Study.
MedComm (2020)
Huang J, Wang Y, Sun H, Min J, Yang N, Yu Q, Cheng Y, Zhao Y, Li M, Chen H, Ren S, Zhou J, Zhuang W, Qin X, Cao L, Yu Y, Zhang J, He J, Feng J, Yu H, Zhang L, Zhao X, Fang W, Li J, Zhang L, Yang Y.
PMID: 42830869 [PubMed]
At-home subcutaneous atezolizumab for non-small cell lung cancer: a prospective, single-arm phase II feasibility study.
Lung Cancer Manag
Yang L, Mutalib SI, Qi E, Zeng A, Thomas J, Hsu R, Kuhn P, Nocera L, Nieva J.
PMID: 42830627 [PubMed]
Systemic Immune-Inflammation Index is Associated with Pressure Injury in Hospitalized Patients with Non-Small Cell Lung Cancer: A Retrospective Cohort Study.
Cancer Manag Res
Liu J, Wang J.
PMID: 42829614 [PubMed]
Identification of a Novel Subtype-Derived Prognostic Signature Based on Nucleotide Metabolism-Related Molecular Classification for Predicting Lung Adenocarcinoma Prognosis.
Int J Genomics
Shi Y, Li S, Zhao L, Li Y, Cai F, Wang K, Xu N, Liu B, Zhou F, Cui Y, Shi C, Bai X, Zhang J.
PMID: 42829577 [PubMed]
Artikel 1 - 20 / 163544
Seite 1 von 8178
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung